These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

751 related items for PubMed ID: 17370330

  • 1. Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.
    Belli LS, Burroughs AK, Burra P, Alberti AB, Samonakis D, Cammà C, De Carlis L, Minola E, Quaglia A, Zavaglia C, Vangeli M, Patch D, Dhillon A, Cillo U, Guido M, Fagiuoli S, Giacomoni A, Slim OA, Airoldi A, Boninsegna S, Davidson BR, Rolles K, Pinzello G.
    Liver Transpl; 2007 May; 13(5):733-40. PubMed ID: 17370330
    [Abstract] [Full Text] [Related]

  • 2. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C.
    Rayhill SC, Wu YM, Katz DA, Voigt MD, Labrecque DR, Kirby PA, Mitros FA, Kalil RS, Miller RA, Stolpen AH, Schmidt WN.
    Transplantation; 2007 Aug 15; 84(3):331-9. PubMed ID: 17700157
    [Abstract] [Full Text] [Related]

  • 3. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE.
    Liver Transpl; 2009 Dec 15; 15(12):1872-81. PubMed ID: 19938138
    [Abstract] [Full Text] [Related]

  • 4. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
    Berenguer M, Aguilera V, Prieto M, Carrasco D, Rayón M, San Juan F, Landaverde C, Mir J, Berenguer J.
    Liver Transpl; 2003 Nov 15; 9(11):1152-8. PubMed ID: 14586875
    [Abstract] [Full Text] [Related]

  • 5. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
    Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Cabrera R, Shuster JJ, Theriaque D, Reed AI, Hemming AW, Liu C, Crawford JM, Nelson DR.
    Liver Transpl; 2004 Oct 15; 10(10):1240-7. PubMed ID: 15376304
    [Abstract] [Full Text] [Related]

  • 6. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
    Rosen HR, Shackleton CR, Higa L, Gralnek IM, Farmer DA, McDiarmid SV, Holt C, Lewin KJ, Busuttil RW, Martin P.
    Am J Gastroenterol; 1997 Sep 15; 92(9):1453-7. PubMed ID: 9317061
    [Abstract] [Full Text] [Related]

  • 7. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients.
    Berenguer M, Prieto M, San Juan F, Rayón JM, Martinez F, Carrasco D, Moya A, Orbis F, Mir J, Berenguer J.
    Hepatology; 2002 Jul 15; 36(1):202-10. PubMed ID: 12085366
    [Abstract] [Full Text] [Related]

  • 8. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
    Botha JF, Thompson E, Gilroy R, Grant WJ, Mukherjee S, Lyden ER, Fox IJ, Sudan DL, Shaw BW, Langnas AN.
    Liver Int; 2007 Aug 15; 27(6):758-63. PubMed ID: 17617118
    [Abstract] [Full Text] [Related]

  • 9. Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: a retrospective analysis of 939 liver biopsies in a single center.
    Walter T, Dumortier J, Guillaud O, Hervieu V, Scoazec JY, Boillot O.
    Liver Transpl; 2007 Feb 15; 13(2):294-301. PubMed ID: 17256784
    [Abstract] [Full Text] [Related]

  • 10. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.
    Liver Transpl; 2009 Apr 15; 15(4):390-9. PubMed ID: 19326408
    [Abstract] [Full Text] [Related]

  • 11. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
    Selzner N, Girgrah N, Lilly L, Guindi M, Selzner M, Therapondos G, Adeyi O, McGilvray I, Cattral M, Greig PD, Grant D, Levy G, Renner EL.
    Liver Transpl; 2008 Dec 15; 14(12):1778-86. PubMed ID: 19025914
    [Abstract] [Full Text] [Related]

  • 12. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE.
    Liver Transpl; 2006 Apr 15; 12(4):560-5. PubMed ID: 16555313
    [Abstract] [Full Text] [Related]

  • 13. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts.
    Khapra AP, Agarwal K, Fiel MI, Kontorinis N, Hossain S, Emre S, Schiano TD.
    Liver Transpl; 2006 Oct 15; 12(10):1496-503. PubMed ID: 16964597
    [Abstract] [Full Text] [Related]

  • 14. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P, Samonakis D, Cholongitas E, Patch D, O'Beirne J, Dhillon AP, Rolles K, McCormick A, Hayes P, Burroughs AK.
    Liver Transpl; 2009 Dec 15; 15(12):1783-91. PubMed ID: 19938143
    [Abstract] [Full Text] [Related]

  • 15. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M, Berenguer M, Rayón JM, Córdoba J, Argüello L, Carrasco D, García-Herola A, Olaso V, De Juan M, Gobernado M, Mir J, Berenguer J.
    Hepatology; 1999 Jan 15; 29(1):250-6. PubMed ID: 9862874
    [Abstract] [Full Text] [Related]

  • 16. Mortality predictors in liver transplant recipients with recurrent hepatitis C cirrhosis.
    Saab S, Niho H, Comulada S, Hiatt J, Durazo F, Han S, Farmer DG, Holt C, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW.
    Liver Int; 2005 Oct 15; 25(5):940-5. PubMed ID: 16162150
    [Abstract] [Full Text] [Related]

  • 17. A model to predict severe HCV-related disease following liver transplantation.
    Berenguer M, Crippin J, Gish R, Bass N, Bostrom A, Netto G, Alonzo J, Garcia-Kennedy R, Rayón JM, Wright TL.
    Hepatology; 2003 Jul 15; 38(1):34-41. PubMed ID: 12829984
    [Abstract] [Full Text] [Related]

  • 18. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.
    Dig Liver Dis; 2009 May 15; 41(5):350-6. PubMed ID: 19046932
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation.
    McTaggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S.
    Liver Transpl; 2004 Aug 15; 10(8):975-85. PubMed ID: 15390322
    [Abstract] [Full Text] [Related]

  • 20. The natural history of hepatitis C cirrhosis after liver transplantation.
    Firpi RJ, Clark V, Soldevila-Pico C, Morelli G, Cabrera R, Levy C, Machicao VI, Chaoru C, Nelson DR.
    Liver Transpl; 2009 Sep 15; 15(9):1063-71. PubMed ID: 19718647
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.